Injective has partnered with global investment platform Republic to enhance access to tokenized private market investing and bring institutional-grade finance onto the blockchain. Announced in a press release on August 21, the collaboration marks the next step in Injective’s effort to merge blockchain infrastructure with traditional financial assets.
Widening tokenized investment opportunities
Through this integration, Injective now supports the Republic Wallet, providing its 3 million members across 150 countries with direct access to Injective-native assets. A dedicated launchpad for Injective-based projects will also be established, enabling institutions and startups to tap directly into Republic’s extensive network of accredited and retail investors.
Republic has earned a strong reputation in tokenization and private markets, helping over 3,000 ventures raise more than $3 billion in funding. Its portfolio includes over two dozen unicorns, such as SpaceX, Robinhood, and Carta. Through its partnership with Injective, Republic moves beyond its role as a network validator to a deeper collaboration aimed at boosting on-chain fundraising and expanding access to tokenized investment products.
Boosting institutional adoption
As a FINRA-registered funding platform with regulatory approvals across the U.S., UK, EU, and Asia, Republic brings substantial institutional credibility to the Injective ecosystem.
The partnership merges Republic’s tokenization expertise with Injective’s purpose-built blockchain for finance, which already supports real-world asset markets including tokenized Nvidia chips, equities, and structured products.
The tokenization market is projected to reach $50 billion by year-end, up from $35 billion today. Leveraging Injective’s high-performance infrastructure and Republic’s compliance framework, the integration is expected to accelerate the co-development of innovative tokenized products.
Recent milestones—such as the launch of the first on-chain Digital Asset Treasury with tokenized ETH exposure, markets for Nvidia’s H100 chips, and other equity-linked products—highlight Injective’s growing role in bridging traditional finance and DeFi. With Republic’s support, Injective is positioning itself as a key player in democratizing blockchain-based private investment opportunities.
